2Lindh M, Savage K, Rees J, et al. HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B. Liver, 1999, 19: 294- 298.
3Cheng PN, Liu WC, Tsai HW, et al. Association of intrahepatic cccDNA reduction with the improvenment of liver histology in chronic hepatitis B patients receiving oral antiviral agents. J Med Virol, 2011, 83: 602-607.
4Marcellin P, Chang TT, Lim SG, et al. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen- positive chronic hepatitis B. Hepatology, 2008, 48: 750-758.
5Poynard T, Ngo Y, Marcellin P, et al. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest- ActiTest) in patients infected by hepatitis B virus. J V'tral Hepat, 2009, 16: 203-213.
